En un ensayo clnico de fase 2, la semaglutida a dosis de 0,4mg diarios mostr una resolucin de NASH (sin empeoramiento de fibrosis) en un 59% de los pacientes, comparado con un 14% en el grupo placebo, en 320 pacientes con obesidad, NASH y fibrosis F2-F3 tras 72 semanas de tratamiento
Researchers have linked Ozempic and similar weight loss drugs to several serious side effects, including stomach paralysis (gastroparesis), bowel obstruction, gallbladder disease, vision loss (such as NAION), pancreatitis, and a possible increased risk of thyroid cancer
It may occasionally help with puffiness or fluid retention, but it should not be viewed as a weight loss drug
In addition to L-Carnitine, the formula also contains Vitamin B5 (Calcium D-Pantothenate), which helps support energy metabolism and overall performance
Retrieved January 25, 2019